pocketful logo light
pocketful logo light
Ind-Swift Laboratories Ltd logo

Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB BSE: 532305

₹187.38

(11.09%)

Thu, 25 Jun 2026, 05:14 am

Ind-Swift Laboratories Share Price Live Chart

1 Day

(11.09%)

No Result Found

Summary

  • Market Cap (in Cr)

    1321.38

  • Net Profit (in Cr)

    250.53

  • P/B

    0.53

  • Sector P/E

    33.76

  • P/E

    2.30

  • EV/EBITDA

    0.62

  • Debt/Equity (Industry)

    0.24

  • Interest Cover (Industry)

    9.79

  • ROCE (Industry)

    14.04

  • RONW (Industry)

    13.17

  • ROE

    0.14

  • ROCE

    0.63

  • Debt/Equity

    0.11

  • EPS (TTM)

    5.69

  • Dividend Yield

    0

  • Book Value

    159.17

  • Interest Cover

    3.01

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters42.9939.5039.5040.9440.94
FII13.8814.3314.804.273.07
DII0.000.680.680.910.91
Public43.1245.5045.0253.8755.07
Government00000

Read More

Technical Analysis

RSI

83.52

MACD

13.13

50 DMA

150.02

200 DMA

121.51

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic210.85179.16165.64147.47133.95115.7884.09
Fibonacci179.16167.06159.58147.47135.37127.89115.78
Camarilla160.82157.92155.01147.47149.21146.30143.40

Pivots Level: Classic

R3

+63.38

210.85

R2

+31.69

179.16

R1

+18.16

165.64

147.47
147.47
Pivot Point
LTP: 202.32

S1

-13.53

133.95

S2

-31.69

115.78

S3

-63.38

84.09

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    182.37

  • 20-EMA

    170.87

  • 30-EMA

    163.95

  • 50-EMA

    155.56

  • 100-EMA

    143.03

  • 200-EMA

    129.32

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
28 May 2026board-meetingsAccounts
31 Jan 2026board-meetingsQuarterly Results, Nine Months Results
14 Nov 2025board-meetingsQuarterly Results
25 Aug 2025agm
20 Jan 2025egm
02 Sept 2024agm
24 Aug 2024agmAnnual General Meeting25 Sept 2024
28 Jun 2024egm
06 Sept 2023egm
31 Aug 2023agm

Read More

Peer Comparison

Ind-Swift Laboratories Ltd logo

Ind-Swift Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Ind-Swift Laboratories Ltd About

Ind-Swift Laboratories as an API manufacturer the Company has shifted its focus to formulation as its key business driver.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

1995

Headquarters

CEO

N R Munjal

Employees

Contact

Website icon

Website

http://www.indswiftlabs.com

Email icon

Email

investor@indswiftlabs.com, info@indswiftlabs.com

Phone icon

Phone

91-0172-5061850/2730920

Location icon

Location

SCO 850 Shivalik Enclave, NAC Manimajra, Chandigarh, Chandigarh, 160101

Read More

Ind-Swift Laboratories Ltd Company History

YearHistory
2013
  • R K Ummat was appointed as an Independent Director on the Board of the Company.
2014
  • Dr. Vinay Kumar Arora was appointed as an Independent Director.
2018
  • The company acquired KEC Bikaner Sikar Transmission Private Limited.
2020
  • Ind-Swift Labs tied up with a reputed generic player in the USA to launch generic Fexofenadine.
2021
  • Ind-Swift Laboratories Limited received the North India Best Employer Award.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
HRTI PRIVATE LIMITEDbulkSell202663153.0429 May 2026
HRTI PRIVATE LIMITEDbulkBuy670635155.129 May 2026
HCP INVESTMENTSbulkSell700000131.1420 Apr 2026
NOVA GLOBAL OPPORTUNITIES FUND PCC - TOUCHSTONEbulkBuy803387138.0717 Apr 2026
SHARE INDIA SECURITIES LIMITEDbulkBuy689971134.2817 Apr 2026
MANSI SHARE AND STOCK BROKING PRIVATE LIMITEDbulkBuy798784132.6617 Apr 2026
SAHASTRAA ADVISORS PRIVATE LIMITEDbulkBuy475000131.7417 Apr 2026
F3 ADVISORS PRIVATE LIMITEDbulkBuy702431133.2517 Apr 2026
PARTH INFIN BROKERS PVT LTDbulkBuy478673132.7617 Apr 2026
D3 STOCK VISION LLPbulkBuy479361132.3817 Apr 2026

Read More

Ind-Swift Laboratories Ltd News

Ind-Swift Laboratories amends insider trading policy

Ind-Swift Laboratories Ltd amended its Code of Fair Disclosure and Insider Trading Policy on June 22, 2026, to align with SEBI regulations.

22 Jun 2026

companies

Ind-Swift Labs director resigns

Prabhat Khurana resigns as Independent Director of Ind-Swift Laboratories Limited effective June 22, 2026, citing personal commitments.

22 Jun 2026

companies

Ind-Swift Labs Board Meet on May 28

Ind-Swift Laboratories Ltd. will hold a board meeting on May 28, 2026, to consider Q4 and FY26 audited financial results. The meeting will cover standalone and consolidated figures.

22 May 2026

companies

Ind-Swift Labs Passes 4 Special Resolutions via Postal Ballot

Ind-Swift Laboratories passes 4 special resolutions via postal ballot on April 30, 2026, including MD appointments and remuneration approval, with over 99.87% votes in favour.

05 May 2026

companies

HCP Investments Sells 7.5% Stake in Ind-Swift Labs

HCP Investments disposed of 6,503,423 equity shares representing 7.5% stake in Ind-Swift Laboratories through open market transactions between April 13-17, 2026, reducing its holding to 1.149%.

23 Apr 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number